2006年

Different anti-HCV profiles of statins and their potential for combination therapy with interferon.
Ikeda M, Abe K, Yamada M, Dansako H, Naka K, Kato N.
Hepatology, 44(1):117-25 (2006)

The NS3 protein of hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner.
Deng L, Nagano-Fujii M, Tanaka M, Nomura-Takigawa Y, Ikeda M, Kato N, Sada K, Hotta H.
J. Gen. Virol., 87(6):1703-13 (2006)

Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling without replicating viral genome.
Naka K, Dansako H, Kobayashi N, Ikeda M, Kato N.
Virology, 346(2):348-62 (2006)

Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cells.
Naka K, Abe K, Takemoto K, Dansako H, Ikeda M, Shimotohno K, Kato N.
J. Hepatol., 44(5):869-78 (2006)

Zinc is a negative regulator of hepatitis C virus RNA replication.
Yuasa K, Naganuma A, Sato K, Ikeda M, Kato N, Takagi H, Mori M.
Liver Int., 26(9):1111-8 (2006)